Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study

Bomben, Riccardo

•

Rossi, Francesca Maria

•

Vit, Filippo

altro

Gattei, Valter

2023

journal article

Periodico

LEUKEMIA

Abstract

N/A

DOI

10.1038/s41375-023-01845-9

WOS

WOS:000936212800002

Archivio

https://hdl.handle.net/11368/3085265

info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85148347118

https://www.nature.com/articles/s41375-023-01845-9

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079531/

Diritti

open access

license:creative commons

license:digital rights management non definito

license uri:http://creativecommons.org/licenses/by/4.0/

license uri:iris.pri00

FVG url

https://arts.units.it/bitstream/11368/3085265/1/Bomben_Leukemia_2023.pdf

Soggetti